Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+ CD11b+ myeloid cells that promote metastasis L Yang, J Huang, X Ren, AE Gorska, A Chytil, M Aakre, DP Carbone, ... Cancer cell 13 (1), 23-35, 2008 | 1123 | 2008 |
Chemokines and chemokine receptors: new insights into cancer-related inflammation G Lazennec, A Richmond Trends in molecular medicine 16 (3), 133-144, 2010 | 807 | 2010 |
Role of chemokines in tumor growth D Raman, PJ Baugher, YM Thu, A Richmond Cancer letters 256 (2), 137-165, 2007 | 758 | 2007 |
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity CL Addison, TO Daniel, MD Burdick, H Liu, JE Ehlert, YY Xue, L Buechi, ... The Journal of Immunology 165 (9), 5269-5277, 2000 | 742 | 2000 |
Mouse xenograft models vs GEM models for human cancer therapeutics A Richmond, Y Su Disease models & mechanisms 1 (2-3), 78-82, 2008 | 588 | 2008 |
NF-κB, chemokine gene transcription and tumour growth A Richmond Nature Reviews Immunology 2 (9), 664-674, 2002 | 587 | 2002 |
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ... Nature communications 7 (1), 10582, 2016 | 537 | 2016 |
Delayed wound healing in CXCR2 knockout mice RM Devalaraja, LB Nanney, Q Qian, J Du, Y Yu, MN Devalaraja, ... Journal of investigative dermatology 115 (2), 234-244, 2000 | 496 | 2000 |
Chemokines in health and disease D Raman, T Sobolik-Delmaire, A Richmond Experimental cell research 317 (5), 575-589, 2011 | 474 | 2011 |
Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin. A Richmond, E Balentien, HG Thomas, G Flaggs, DE Barton, J Spiess, ... The EMBO journal 7 (7), 2025-2033, 1988 | 428 | 1988 |
Role of CXCL1 in tumorigenesis of melanoma P Dhawan, A Richmond Journal of leukocyte biology 72 (1), 9-18, 2002 | 405 | 2002 |
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer D Wang, H Wang, J Brown, T Daikoku, W Ning, Q Shi, A Richmond, ... The Journal of experimental medicine 203 (4), 941-951, 2006 | 397 | 2006 |
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity M Pruenster, L Mudde, P Bombosi, S Dimitrova, M Zsak, J Middleton, ... Nature immunology 10 (1), 101-108, 2009 | 387 | 2009 |
Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator GM Walker, J Sai, A Richmond, M Stremler, CY Chung, JP Wikswo Lab on a Chip 5 (6), 611-618, 2005 | 334 | 2005 |
Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-κB and tumor progression P Dhawan, AB Singh, DL Ellis, A Richmond Cancer research 62 (24), 7335-7342, 2002 | 331 | 2002 |
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes E Schutyser, A Richmond, J Van Damme Journal of leukocyte biology 78 (1), 14-26, 2005 | 330 | 2005 |
A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells P Dhawan, A Richmond Journal of Biological Chemistry 277 (10), 7920-7928, 2002 | 321 | 2002 |
Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy AE Vilgelm, A Richmond Frontiers in immunology 10, 333, 2019 | 318 | 2019 |
Chemokine receptor internalization and intracellular trafficking NF Neel, E Schutyser, J Sai, GH Fan, A Richmond Cytokine & growth factor reviews 16 (6), 637-658, 2005 | 305 | 2005 |
Role of nuclear factor-κ B in melanoma KI Amiri, A Richmond Cancer and Metastasis Reviews 24, 301-313, 2005 | 264 | 2005 |